SCHEMBL23011877

SCHEMBL23011877

CC1(C)Oc2ccc(Nc3[nH]ncc3F)nc2NC1=O

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ SYK P43405 7/20 0.51
▸ ADORA3 P0DMS8 2/20 0.51
▸ TYRO3 Q06418 2/20 0.51
▸ BMPR1B O00238 1/20 0.51
▸ CDC7 O00311 1/20 0.51
▸ PIK3CD O00329 1/20 0.51
▸ PLK4 O00444 1/20 0.51
▸ STK25 O00506 1/20 0.51
▸ CIT O14578 1/20 0.51
▸ RIOK3 O14730 1/20 0.51
▸ CHEK1 O14757 1/20 0.51
▸ IKBKB O14920 1/20 0.51
▸ AURKA O14965 1/20 0.51
▸ GAK O14976 1/20 0.51
▸ CHUK O15111 1/20 0.51
▸ MUSK O15146 1/20 0.51
▸ EPHB6 O15197 1/20 0.51
▸ MAPK13 O15264 1/20 0.51
▸ PDPK1 O15530 1/20 0.51
▸ DAPK3 O43293 1/20 0.51

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1083288 0.76 SYK (0.62) SYKADORA3TYRO3BMPR1BCDC7
SCHEMBL12854262 0.76 SYK (0.69) SYKADORA3TYRO3BMPR1BCDC7
SCHEMBL22068257 0.76 SYK (0.69) SYKADORA3TYRO3BMPR1BCDC7
SCHEMBL14235384 0.76 SYK (0.49) SYKADORA3TYRO3BMPR1BCDC7
SCHEMBL12212784 0.73 SYK (0.66) SYKADORA3TYRO3BMPR1BCDC7
SCHEMBL12237025 0.73 SYK (0.66) SYKADORA3TYRO3BMPR1BCDC7
SCHEMBL14213425 0.72 SYK (0.47) SYKADORA3TYRO3BMPR1BCDC7
SCHEMBL2627048 0.72 SYK (0.72) SYKADORA3TYRO3BMPR1BCDC7
SCHEMBL2523179 0.71 SYK (0.70) SYKADORA3TYRO3BMPR1BCDC7
SCHEMBL16606964 0.70 SYK (0.52) SYKADORA3TYRO3BMPR1BCDC7

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4013420-B1 METHOD OF BLOCKING OR AMELIORATING CYTOKINE RELEASE SYNDROME RIGEL PHARMACEUTICALS INC (US) 2023-11-01 — — EP disclosed
WO-2021030526-A1 METHOD OF BLOCKING OR AMELIORATING CYTOKINE RELEASE SYNDROME RIGEL PHARMACEUTICALS, INC. (US) 2021-02-18 — — WO disclosed
Send feedback